29 Apr 2013 12:15
London, 29 April 2013
Silence Therapeutics plc ("Silence Therapeutics" or the "Company")
Result of General Meeting
Silence Therapeutics announces that at its General Meeting held earlier today, the resolutions as set out in the circular send to shareholders on 10 April 2013 in reference to the Placing of New Ordinary Shares and Share Consolidation were duly passed.
Silence Therapeutics
Tim Freeborn, finance director
+44 (0) 333 988 0140
t.freeborn@silence-therapeutics.com
N+1 Singer
Shaun Dobson/Jenny Wyllie
+44 20 7496 3057
shaun.dobson@n1singer.com
jenny.wyllie@n1singer.com